Autolus Therapeutics plc (NASDAQ:AUTL) is a top stock under $5 with high growth potential, recently receiving a Buy rating and $10 price target from Needham analyst Gil Blum.
Read MoreDid you find this insightful?
Bad
Just Okay
Amazing
Autolus Therapeutics plc (NASDAQ:AUTL) is a top stock under $5 with high growth potential, recently receiving a Buy rating and $10 price target from Needham analyst Gil Blum.
Read MoreDid you find this insightful?
Bad
Just Okay
Amazing